相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients
Sergio Occhipinti et al.
CLINICAL CANCER RESEARCH (2014)
Immunogenicity and Therapeutic Efficacy of a Dual-Component Genetic Cancer Vaccine Cotargeting Carcinoembryonic Antigen and HER2/neu in Preclinical Models
Luigi Aurisicchio et al.
HUMAN GENE THERAPY (2014)
Direct T Cell Activation via CD40 Ligand Generates High Avidity CD8+ T Cells Capable of Breaking Immunological Tolerance for the Control of Tumors
Ruey-Shyang Soong et al.
PLOS ONE (2014)
Intramuscular Therapeutic Vaccination Targeting HPV16 Induces T Cell Responses That Localize in Mucosal Lesions
Leonel Maldonado et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Cancer-testis antigen MAGE-C2/CT10 induces spontaneous CD4+ and CD8+ T-cell responses in multiple myeloma patients
H. Reinhard et al.
BLOOD CANCER JOURNAL (2014)
Tumor Subtype-Specific Cancer-Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
Jun Yao et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells
Venkataswarup Tiriveedhi et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Innovative DNA Vaccine to Break Immune Tolerance Against Tumor Self-Antigen
Tae Heung Kang et al.
HUMAN GENE THERAPY (2013)
DNA fusion vaccine designs to induce tumor-lytic CD8+T-cell attack via the immunodominant cysteine-containing epitope of NY-ESO 1
Juan Campos-Perez et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors
Claudia Marcela Diaz-Montero et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Xenogeneic Human p53 DNA Vaccination by Electroporation Breaks Immune Tolerance to Control Murine Tumors Expressing Mouse p53
Ruey-Shyang Soong et al.
PLOS ONE (2013)
Highly Optimized DNA Vaccine Targeting Human Telomerase Reverse Transcriptase Stimulates Potent Antitumor Immunity
Jian Yan et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination
Kouji Kobiyama et al.
VACCINES (2013)
The cancer testis antigen PRAME as a biomarker for solid tumor cancer management
Steve Goodison et al.
BIOMARKERS IN MEDICINE (2012)
DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time
Lindsey Chudley et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients
Kunle Odunsi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses
Mark L. Bagarazzi et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination
Christophe J. Desmet et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Translating Tumor Antigens into Cancer Vaccines
Luigi Buonaguro et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Electroporation delivery of DNA vaccines: prospects for success
Niranjan Y. Sardesai et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
A Phase I safety study of plasmid DNA immunization targeting carcinoembryonic antigen in colorectal cancer patients
Caroline Staff et al.
VACCINE (2011)
Immunologic Response to Xenogeneic gp100 DNA in Melanoma Patients: Comparison of Particle-Mediated Epidermal Delivery with Intramuscular Injection
Brian A. Ginsberg et al.
CLINICAL CANCER RESEARCH (2010)
JAVMA News
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2010)
DNA Vaccines: Developing New Strategies against Cancer
Daniela Fioretti et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) Elicits Long-term T-cell Responses in Patients With Recurrent Prostate Cancer
Jordan T. Becker et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial
Hakan Norell et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma
D. Joseph-Pietras et al.
LEUKEMIA (2010)
Cancer Genome Sequencing-An Interim Analysis
Edward J. Fox et al.
CANCER RESEARCH (2009)
Cancer/testis (CT) antigens: Potential targets for immunotherapy
Otavia L. Caballero et al.
CANCER SCIENCE (2009)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3
Cornelia L. Trimble et al.
CLINICAL CANCER RESEARCH (2009)
DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer
Lindsey Low et al.
HUMAN GENE THERAPY (2009)
Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer
Douglas G. McNeel et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Hiroki Ishikawa et al.
NATURE (2009)
Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures
Maurizio Bendandi
NATURE REVIEWS CANCER (2009)
Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer
Benjamin B. Williams et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma
Jeffrey Weber et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo Electroporation
Jinyan Liu et al.
JOURNAL OF VIROLOGY (2008)
TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines
Ken J. Ishii et al.
NATURE (2008)
DNA vaccines: precision tools for activating effective immunity against cancer
Jason Rice et al.
NATURE REVIEWS CANCER (2008)
In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells
Gustaf Ahlen et al.
JOURNAL OF IMMUNOLOGY (2007)
Plasmid DNA and viral vector-based vaccines for the treatment of cancer
Richard J. Anderson et al.
VACCINE (2007)
Canine oral melanoma
Philip J. Bergman
CLINICAL TECHNIQUES IN SMALL ANIMAL PRACTICE (2007)
Unique human tumor antigens: Immunobiology and use in clinical trials
Giorgio Parmiani et al.
JOURNAL OF IMMUNOLOGY (2007)
Towards progress on DNA vaccines for cancer
D. B. Lowe et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
DNA tumor viruses and human cancer
Blossom Damania
TRENDS IN MICROBIOLOGY (2007)
How will HPV vaccines affect cervical cancer?
Richard Roden et al.
NATURE REVIEWS CANCER (2006)
Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases
Deborah H. Fuller et al.
METHODS (2006)
Feasibilty of in utero DNA vaccination following naked gene transfer into pig fetal muscle:: Transgene expression, immunity and safety
Monica Rinaldi et al.
VACCINE (2006)
Adjuvant activity of CpG oligodeoxynucleotides
Dennis M. Klinman
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2006)
Agonist anti-GITR antibody enhances vaccine-induced CD8+ T-cell responses and tumor immunity
AD Cohen et al.
CANCER RESEARCH (2006)
Insufficient APC capacities of dendritic cells in gene gun-mediated DNA vaccination
Henning Lauterbach et al.
JOURNAL OF IMMUNOLOGY (2006)
Central tolerance: good but imperfect
AM Gallegos et al.
IMMUNOLOGICAL REVIEWS (2006)
A listing of human tumor antigens recognized by T cells: March 2004 update
L Novellino et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
An antigenic peptide produced by peptide splicing in the proteasome
N Vigneron et al.
SCIENCE (2004)
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems
PD Gregor et al.
VACCINE (2004)
Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe
C Trimble et al.
VACCINE (2003)
Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways
WW Leitner et al.
NATURE MEDICINE (2003)
Identification of HLA-A3-restricted CD8+T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer
A Jaramillo et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Tumor-specific shared antigenic peptides recognized by human T cells
P van der Bruggen et al.
IMMUNOLOGICAL REVIEWS (2002)
Electroporation improves the efficacy of DNA vaccines in large animals
S Babiuk et al.
VACCINE (2002)
Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation
S Tollefsen et al.
VACCINE (2002)
Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: A review
NL Berinstein
JOURNAL OF CLINICAL ONCOLOGY (2002)
The T-cell repertoire available for recognition of self-antigens
HTC Kreuwel et al.
CURRENT OPINION IN IMMUNOLOGY (2001)
Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice
M Dupuis et al.
JOURNAL OF IMMUNOLOGY (2000)
Plasmid DNA vaccines: Investigation of integration into host cellular DNA following intramuscular injection in mice
BJ Ledwith et al.
INTERVIROLOGY (2000)
Increased DNA vaccine delivery and immunogenicity by electroporation in vivo
G Widera et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
